This result was somewhat unexpected but not totally surprising, as these data are similar to previously published work on ERK5 oncogene deletion, which accelerated in vivo tumor growth while inhibiting tumor invasion of breast cancer cells [57]. The gene discussed is MAPK7; the disease is breast carcinoma.